PLUS vs RMD · P/E 17, rev $2.07B vs P/E 29, $37.68B cap
ePlus inc (PLUS) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
RMD does not have a complete income-statement cache yet.
PLUS currently screens at market cap $2.10B and trailing P/E 17.1. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the PLUS and RMD stock pages for the full models.
Not investment advice.